CDC logo
Safer Healthier People
CDC Home CDC Search CDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Skip navigation links Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us

Search for NIOSH Publications: NIOSHTIC-2

NIOSHTIC-2 Search Results

      Advanced Search  |  Help  |  About  |  Feedback 
Terms: glutaraldehyde
6 - 6 of 60 Bibliographic entries
Save All   |   Save Page
View Saved    |    Download
Select check boxes to automatically save entries, or use 'save all' or 'save page' links above.
Back to Results
The use of e-cadherin immunofluorescence in pulmonary toxicologic pathology studies.
Authors
Battelli-LA; Castranova-V; Porter-DW; Friend-S; Schwegler-Berry-D; Willard-P; Hubbs-AF
Source
Toxicologist 2011 Mar; 120(Suppl 2):123
Link
http://www.toxicology.org/ms/AMpubs.asp 
NIOSHTIC No.
20038452 
Abstract
E-cadherin is a calcium dependent adhesion molecule with important roles in epithelial intercellular adhesion and cellular structure. Immunofluorescent staining can localize and quantify protein expression in cells or tissues. Co-localization of 2 or more different proteins used in combination with fluorochromes of different colors can reveal the location of each protein. We investigated the use of e-cadherin immunofluorescence in different species (rat and mouse), with different fixatives (10% neutral buffered formalin, 4% paraformaldehyde, and 2.5% glutaraldehyde), with and without antigen retrieval, and as a dual label with immunofluorescence for other proteins. Mouse monoclonal anti-e-cadherin antibodies (BD Biosciences, San Jose, CA) in conjunction with fluorochrome-conjugated donkey anti-mouse antibodies clearly delineated sites of e-cadherin expression in lungs of rats or mice. EDTA heat-induced epitope retrieval was required to restore antigenicity to fixed tissues. E-cadherin could be demonstrated in formalin or paraformaldehyde fixed tissues but not in glutaraldehyde fixed tissue. Immunofluorescent double-labeling with e-cadherin can be used with immunofluorescent detection of podoplanin, a lymphatic endothelial cell marker that is also expressed by alveolar type I cells in the lung. Low levels of e-cadherin expression in type I cells allowed the double labeled type I cells to be distinguished from lymphatic endothelium and facilitated diagnosis of lymphangiectasia. E-cadherin immunofluorescent double labeling can also be used with activated caspase 3 or â-catenin immunofluorescence to localize the expression of these proteins in damaged airways. Thus, in the lung, e-cadherin immunofluorescence can demonstrate abnormal and normal epithelial cell junctions, facilitate demonstration of airway epithelial changes, and distinguish podoplaninexpressing alveolar type I cells from lymphatic endothelium.
Keywords
Biological-effects; Cell-biology; Cell-function; Cellular-function; Cellular-reactions; Dose-response; Exposure-levels; Immune-reaction; Laboratories; Laboratory-testing; Lung-cells; Lymphatic-system; Lymphocytes; Physiological-effects; Pulmonary-function; Pulmonary-system; Quantitative-analysis; Respiratory-function-tests; Statistical-analysis; Toxic-effects
CAS No.
7440-70-2
Publication Date
20110301
Document Type
Abstract
Fiscal Year
2011
NTIS Accession No.
NTIS Price
ISSN
1096-6080
NIOSH Division
HELD
Source Name
The Toxicologist. Society of Toxicology 50th Annual Meeting and ToxExpo, Washington, DC, March 6-10, 2011
State
WV; DC
Page 6 of 60

File Formats Help:

Adobe PDF file
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?double arrows.